Filtros : "Current Pharmaceutical Design" "2017" Limpar

Filtros



Refine with date range


  • Source: Current Pharmaceutical Design. Unidade: IFSC

    Subjects: SCHISTOSOMA MANSONI, ESQUISTOSSOMOSE, INIBIDORES DE ENZIMAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SERRÃO, Vitor Hugo Balasco et al. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target. Current Pharmaceutical Design, v. 23, n. 45, p. 6967-6983, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612823666171011100532. Acesso em: 16 nov. 2025.
    • APA

      Serrão, V. H. B., Souza, J. R. T. de, Romanello, L., & Pereira, H. d'M. (2017). Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target. Current Pharmaceutical Design, 23( 45), 6967-6983. doi:10.2174/1381612823666171011100532
    • NLM

      Serrão VHB, Souza JRT de, Romanello L, Pereira H d'M. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target [Internet]. Current Pharmaceutical Design. 2017 ; 23( 45): 6967-6983.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666171011100532
    • Vancouver

      Serrão VHB, Souza JRT de, Romanello L, Pereira H d'M. Schistosoma mansoni purine and pyrimidine biosynthesis: structures and kinetic experiments in the search for the best therapeutic target [Internet]. Current Pharmaceutical Design. 2017 ; 23( 45): 6967-6983.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666171011100532
  • Source: Current Pharmaceutical Design. Unidade: IFSC

    Subjects: NANOCOMPOSITOS, BIOMATERIAIS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FOLLMANN, Heveline D. M. et al. Hybrid materials and nanocomposites as multifunctional biomaterials. Current Pharmaceutical Design, v. 23, n. 26, p. 3794-3813, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612823666170710160615. Acesso em: 16 nov. 2025.
    • APA

      Follmann, H. D. M., Naves, A. F., Araujo, R. A., Dubovoy, V., Huang, X., Asefa, T., et al. (2017). Hybrid materials and nanocomposites as multifunctional biomaterials. Current Pharmaceutical Design, 23( 26), 3794-3813. doi:10.2174/1381612823666170710160615
    • NLM

      Follmann HDM, Naves AF, Araujo RA, Dubovoy V, Huang X, Asefa T, Silva R, Oliveira Junior ON de. Hybrid materials and nanocomposites as multifunctional biomaterials [Internet]. Current Pharmaceutical Design. 2017 ; 23( 26): 3794-3813.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666170710160615
    • Vancouver

      Follmann HDM, Naves AF, Araujo RA, Dubovoy V, Huang X, Asefa T, Silva R, Oliveira Junior ON de. Hybrid materials and nanocomposites as multifunctional biomaterials [Internet]. Current Pharmaceutical Design. 2017 ; 23( 26): 3794-3813.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612823666170710160615
  • Source: Current Pharmaceutical Design. Unidade: FCF

    Subjects: SOLUBILIDADE, NANOTECNOLOGIA, EMULSÕES (FORMAS FARMACÊUTICAS)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Challenges and future prospects of nanoemulsion as a drug delivery system. Current Pharmaceutical Design, v. 23, n. 3, p. 495-508, 2017Tradução . . Disponível em: https://doi.org/10.2174/1381612822666161027111957. Acesso em: 16 nov. 2025.
    • APA

      Yukuyama, M. N., Kato, E. T. M., Loebenberg, R., & Bou-Chacra, N. A. (2017). Challenges and future prospects of nanoemulsion as a drug delivery system. Current Pharmaceutical Design, 23( 3), 495-508. doi:10.2174/1381612822666161027111957
    • NLM

      Yukuyama MN, Kato ETM, Loebenberg R, Bou-Chacra NA. Challenges and future prospects of nanoemulsion as a drug delivery system [Internet]. Current Pharmaceutical Design. 2017 ; 23( 3): 495-508.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666161027111957
    • Vancouver

      Yukuyama MN, Kato ETM, Loebenberg R, Bou-Chacra NA. Challenges and future prospects of nanoemulsion as a drug delivery system [Internet]. Current Pharmaceutical Design. 2017 ; 23( 3): 495-508.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612822666161027111957

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025